Research study Program year 2024 Source: CMS Open Payments

A Phase 1 Study of VX-814

Research payments

$1,188,276

18 payments

Through program year 2024, $1,188,276 in research payments was reported against A Phase 1 Study of VX-814, across 18 payments, paid by Vertex Pharmaceuticals Incorporated.

Paid by: Vertex Pharmaceuticals Incorporated
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2024	Research	$665	1
2021	Research	$8,084	5
2020	Research	$302,235	6
2019	Research	$877,292	6

Breakdown

Who paid Research payments · program years 2019–2024

Vertex Pharmaceuticals Incorporated $1,188,276 18 payments

Who received the money Research payments · program years 2019–2024

Covance Clinical Research Unit Inc. Dallas Clinic Organisation paid for research $890,503 3 payments
Central Florida Pulmonary Group P.A. Organisation paid for research $71,748 1 payment
Covance Clinical Research Unit Inc. Madison Clinic Organisation paid for research $69,826 2 payments
Blessing Corporate Services Organisation paid for research $60,466 2 payments
New Horizons Clinical Research Organisation paid for research $44,044 3 payments
University Of Kansas Medical Center Organisation paid for research $34,517 4 payments
Central Florida Pulmonary Group Organisation paid for research $14,274 1 payment
Blessing Corporate Services Inc. Dba Blessing Health System Organisation paid for research $2,411 1 payment
Covance Clinical Research Unit Inc. Daytona Clinic Organisation paid for research $489 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.